HIV-1 Tat and cocaine mediated synaptopathy in cortical and midbrain neurons is prevented by the isoflavone Equol

Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity

(2015) Mario Ortega et al.   AIDS

HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System

(2015) Sylvia Fitting et al.   CURRENT HIV RESEARCH

Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report

(2014) Han-Zhu Qian et al.   BMC INFECTIOUS DISEASES

HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanism

(2014) Kelly A. Krogh et al.   JOURNAL OF NEUROCHEMISTRY

HIV-1 Transgenic Female Rat: Synaptodendritic Alterations of Medium Spiny Neurons in the Nucleus Accumbens

(2014) Robert F. Roscoe et al.   Journal of Neuroimmune Pharmacology

β-Amyloid1-42, HIV-1Ba-L (Clade B) Infection and Drugs of Abuse Induced Degeneration in Human Neuronal Cells and Protective Effects of Ashwagandha (Withania somnifera) and Its Constituent Withanolide A

(2014) Kesava Rao Venkata Kurapati et al.   PLoS One

Chronic Inflammation and the Role for Cofactors (Hepatitis C, Drug Abuse, Antiretroviral Drug Toxicity, Aging) in HAND Persistence

(2014) Alexander J. Gill et al.   Current HIV/AIDS Reports

Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments

(2013) Jia Yao et al.   BRAIN RESEARCH

HIV-1 Tat protein variants: Critical role for the cysteine region in synaptodendritic injury

(2013) Sarah J. Bertrand et al.   EXPERIMENTAL NEUROLOGY

Synaptodendritic recovery following HIV Tat exposure: Neurorestoration by phytoestrogens

(2013) Sarah J. Bertrand et al.   JOURNAL OF NEUROCHEMISTRY

Mutation of Tyrosine 470 of Human Dopamine Transporter is Critical for HIV-1 Tat-Induced Inhibition of Dopamine Transport and Transporter Conformational Transitions

(2013) Narasimha M. Midde et al.   Journal of Neuroimmune Pharmacology

Molecular and pathologic insights from latent HIV-1 infection in the human brain

(2013) P. Desplats et al.   NEUROLOGY

Ashwagandha (Withania somnifera) Reverses β-Amyloid1-42 Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND)

(2013) Kesava Rao Venkata Kurapati et al.   PLoS One

Gut–brain axis: how the microbiome influences anxiety and depression

(2013) Jane A. Foster et al.   TRENDS IN NEUROSCIENCES

Correlates of Antiretroviral Utilization Among Hospitalized HIV-Infected Crack Cocaine Users

(2012) Rupali Kotwal Doshi et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection

(2012) Erica Weber et al.   JOURNAL OF NEUROVIROLOGY

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

(2012) John F. Cryan et al.   NATURE REVIEWS NEUROSCIENCE

Neuroprotection and Estrogen Receptors

(2012) James W. Simpkins et al.   NEUROENDOCRINOLOGY

Soy Isoflavones Genistein and Daidzein Exert Anti-Apoptotic Actions via a Selective ER-mediated Mechanism in Neurons following HIV-1 Tat1–86 Exposure

(2012) Sheila M. Adams et al.   PLoS One

The Biochemical Anatomy of Cortical Inhibitory Synapses

(2012) Elizabeth A. Heller et al.   PLoS One

Endogenous amyloidogenesis in long-term rat hippocampal cell cultures

(2011) Sarah J Bertrand et al.   BMC NEUROSCIENCE

Clinical contributors to cerebral white matter integrity in HIV-infected individuals

(2011) Assawin Gongvatana et al.   JOURNAL OF NEUROVIROLOGY

Neurocognitive Effects of HIV, Hepatitis C, and Substance Use History

(2011) Kathryn N. Devlin et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/HIV-Associated Dementia

(2011) Vishnudutt Purohit et al.   MOLECULAR NEUROBIOLOGY

Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist

(2011) Richard L Jackson et al.   NUTRITION REVIEWS

Human immunodeficiency virus-associated neurocognitive disorder

(2010) Avindra Nath   Annals of the New York Academy of Sciences

Inhibition of Actin Polymerization Prevents Cocaine-induced Changes in Spine Morphology in the Nucleus Accumbens

(2010) Shigenobu Toda et al.   NEUROTOXICITY RESEARCH

ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling

(2010) Sheila M. Adams et al.   SYNAPSE

Dopamine transporter inhibition is necessary for cocaine-induced increases in dendritic spine density in the nucleus accumbens

(2010) Bradley J. Martin et al.   SYNAPSE

Estrogen Receptor Alpha Inhibits the Estrogen-Mediated Suppression of HIV Transcription in Astrocytes: Implications for Estrogen Neuroprotection in HIV Dementia

(2009) Paula M. Heron et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Is equol the key to the efficacy of soy foods?

(2009) Johanna W Lampe   AMERICAN JOURNAL OF CLINICAL NUTRITION

Defining mechanisms of actin polymerization and depolymerization during dendritic spine morphogenesis

(2009) Pirta Hotulainen et al.   JOURNAL OF CELL BIOLOGY

The glutamate homeostasis hypothesis of addiction

(2009) Peter W. Kalivas   NATURE REVIEWS NEUROSCIENCE

Drug Abuse and Hepatitis C Infection as Comorbid Features of HIV Associated Neurocognitive Disorder: Neurocognitive and Neuroimaging Features

(2009) Eileen M. Martin-Thormeyer et al.   NEUROPSYCHOLOGY REVIEW

The human immunodeficiency virus-1–associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: A no-net-flux microdialysis study

(2009) M.J. Ferris et al.   NEUROSCIENCE

Impact of neonatal exposure to the ERα agonist PPT, bisphenol-A or phytoestrogens on hypothalamic kisspeptin fiber density in male and female rats

(2009) Heather B. Patisaul et al.   NEUROTOXICOLOGY

Health-Related Quality of Life in HIV-Infected Patients: The Role of Substance Use

(2008) P. Todd Korthuis et al.   AIDS PATIENT CARE AND STDS

Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons

(2008) Marina V. Aksenova et al.   EXPERIMENTAL NEUROLOGY

Crack-Cocaine Use Accelerates HIV Disease Progression in a Cohort of HIV-Positive Drug Users

(2008) Marianna K Baum et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Human Immunodeficiency Virus Protein Tat Induces Synapse Loss via a Reversible Process That Is Distinct from Cell Death

(2008) H. J. Kim et al.   JOURNAL OF NEUROSCIENCE

Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse

(2008) Linda Chang et al.   NEUROIMAGE

Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons

(2008) Michael Y. Aksenov et al.   NEUROTOXICOLOGY

Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men

(2008) K Fujimoto et al.   PROSTATE CANCER AND PROSTATIC DISEASES

More than a decade of estrogen neuroprotection

(2007) James W. Simpkins et al.   Alzheimers & Dementia